Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions

Publications

Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.

CEP Transcript Request

If you would like a transcript for courses completed prior to 2012, please complete the online enquiry form.


Social

Research shows 87% of Australians believe the government needs to allocate funding for the PBS, yet only 22% believ… https://t.co/tC84XUg8HD

Commitment to health is critical for the future. @MedicinesAus believe that Medicines Matter and increased investme… https://t.co/PPrl1SnwiS

Did you know a one-year increase in life expectancy = 4% rise in GDP? Medicines are integral to helping Australians… https://t.co/f3UGl0seec

A great day at #PharmaDispatch2019 yesterday. The day concluded with a panel session looking to the future with ins… https://t.co/07hbC04VEZ

RT @MSD_Aus: We are so thankful for our hard working team of clinical researchers and all that they do! #MedicinesMatter #ClinicalTrialsDay

Wise words from @belindawood73 of @PSA_National who said at today’s #PharmaDispatch2019 -“If we look at the PBS in… https://t.co/spYQppqF54

Andrew Carter of Commercial Eyes is confident - “We’re going to see a transformational change where it’s about the… https://t.co/vD6QqYF0oA

RT @dr_krystal: The future of healthcare: Final panel for #PharmaDispatch19 discussing vision for medicines industry in age of the empowere…

Some fascinating insights on the future of health in a panel on emerging technologies and the challenge of market a… https://t.co/BhfctBvYet

RT @dr_krystal: Access to medicines matter. @MedicinesAus CEO Liz de Somer on the need to take a long term view on PBS funding & patient ac…

A great panel session to kick off the afternoon on the future of the pharmaceutical supply chain #medicinesmatterhttps://t.co/2fUNTiAxr6

RT @ZarliFrench: @livinglife82 “Thanks to medical #research I’ve seen my daughter start prep my son crawl walk & say mumma” - big reasons…

RT @mexeccareers: Lorraine from @ausbiotech highlights R&D, regenerative medicine, IP issues and MRFF for Australia. @PharmaDispatch #Pha

RT @dr_krystal: Funding for the PBS has been flat or in decline for a decade. A lack of investment in the PBS threatens access to medicines…

Top